Hillhouse Investment

Hillhouse Investment, a key part of the global investment firm Hillhouse Capital Group, was founded in 2005 by Lei Zhang. Headquartered in Singapore, the firm is renowned for its long-term, value-oriented investment philosophy, often described as 'patient capital.' Hillhouse employs a deep research-driven approach, focusing on understanding fundamental industry trends and partnering with exceptional entrepreneurs and management teams across various stages, from early-stage venture to public equities.

The firm's investment strategy spans a diverse range of sectors, including consumer, healthcare, technology, advanced manufacturing, and business services. Hillhouse is particularly active in Asia, where it has built a formidable reputation for identifying and nurturing leading companies. Their approach emphasizes building sustainable competitive advantages and fostering innovation, often through significant capital deployment and strategic guidance.

Hillhouse Investment manages substantial assets, with its Assets Under Management (AUM) frequently reported to be over $60 billion, making it one of the largest investment firms originating from Asia. This considerable capital base allows them to make impactful investments across the capital spectrum. While they can participate in large-scale private equity buyouts and public market investments, their typical first check for private companies generally ranges from a minimum of $2 million for early-stage venture opportunities to a maximum of $250 million for significant growth equity or pre-IPO rounds.

Through its dedicated early-stage investment arm, GL Ventures, Hillhouse actively supports nascent companies from seed to Series B rounds, demonstrating its commitment to fostering innovation from the ground up. This multi-stage investment capability, combined with its deep industry expertise and global network, positions Hillhouse Investment as a powerful and influential force in the global investment landscape, consistently seeking to create long-term value for its partners and portfolio companies.